Putative therapeutic agents for the learning and memory deficits of people with Down syndrome

Putative therapeutic agents for the learning and memory deficits of people with Down syndrome QSAR analysis of pyrazolidine-3,5-diones derivatives as Dyrk1A inhibitors Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics DYRK1A inhibitors for disease therapy: Current status and perspectives Novel Scaffolds for Dual Specificity Tyrosine-Phosphorylation-Regulated Kinase (DYRK1A) Inhibitors DYRK1A kinase inhibition with emphasis on neurodegeneration: A comprehensive evolution story-cum-perspective Discovery and Characterization of Selective and Ligand-Efficient DYRK Inhibitors Novel selective thiadiazine DYRK1A inhibitor lead scaffold with human pancreatic β-cell proliferation activity Structure-Guided Discovery of Potent and Selective DYRK1A Inhibitors Discovery and Optimization of a Novel Series of Dyrk1B Kinase Inhibitors To Explore a MEK Resistance Hypothesis